nitracrine has been researched along with Cancer of Prostate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashok, BT; Banerjee, D; Chen, Y; Garikapaty, VP; Huang, Q; Konopa, J; Tadi, K; Tiwari, RK | 1 |
| Ashok, BT; Banerjee, D; Chen, Y; Darzynkiewicz, Z; Konopa, J; Tadi, K; Tiwari, RK; Wysocka-Skrzela, B | 1 |
2 other study(ies) available for nitracrine and Cancer of Prostate
| Article | Year |
|---|---|
Preclinical toxicological examination of a putative prostate cancer-specific 4-methyl-1-nitroacridine derivative in rodents.
Topics: Animals; Blood; DNA, Neoplasm; Injections, Intraperitoneal; Injections, Intravenous; Kidney; Lethal Dose 50; Liver; Male; Mice; Mice, Inbred BALB C; Nitracrine; Nucleic Acid Hybridization; Prostatic Neoplasms; Rats | 2007 |
Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer.
Topics: Androgen Receptor Antagonists; Animals; Antineoplastic Agents; Cell Line, Tumor; Down-Regulation; Drug Evaluation, Preclinical; Histones; Humans; Intercalating Agents; Male; Mice; Mice, Inbred BALB C; Nitracrine; Prostatic Neoplasms; Xenograft Model Antitumor Assays | 2007 |